1. Appearance: White to off-white crystalline powder (typical morphology of chiral amino acid derivatives; higher purity results in better crystallinity); 2. Solubility: Good water solubility (contain…
1. Appearance: Pale yellow to yellow crystalline powder (contains dinitroaromatic rings; high nitro content leads to coloration, and the higher the purity, the lighter the color); 2. Solubility: Sligh…
1. Appearance: Pale yellow to off-white crystalline powder (contains nitroaromatic ring; the higher the purity, the lighter the color; the nitro group is prone to slight discoloration); 2. Solubility:…
1. Appearance: White to off-white crystalline powder (typical form of a highly complex chiral heterocyclic ester intermediate; higher purity results in better crystallinity); 2. Solubility: Slightly s…
1. Appearance: White to off-white solid; 2. Melting point: >230℃ (sublimation); 3. Solubility: Slightly soluble in water, DMSO, and methanol; 4. Stability: Store at -20℃ under an inert atmosph…
1. Appearance: White to off-white crystalline powder (typical form of a chiral heterocyclic amide intermediate; higher purity results in better crystallinity); 2. Solubility: Excellent water solubilit…
1. Appearance: Pale yellow to light brown oily liquid or low-melting point crystals (common form in industrial grade; the higher the purity, the lighter the color); 2. Solubility: Insoluble in water, …
1. Appearance: White to pale yellow crystalline powder (furanose derivative + aldehyde group, easily oxidized and discolored, the higher the purity, the lighter the color); 2. Solubility: Slightly sol…
Core Applications: 1. Pharmaceutical intermediates: Used in the synthesis of C-aryl glycoside drugs (such as SGLT2 inhibitors, anti-inflammatory drugs), and antiviral drugs (such as nucleoside prodrug…
Molecular Formula (Derived): C₂₉ - C₃₁H₂₆ - ₂₈F₂N₈O (Compared to the final intermediate, the number of C and H atoms may be reduced by 1-3 and 2-4 respectively due to side reactions, while the number …
Core Application: A key intermediate in the final stage of FLT3/JAK kinase inhibitor API synthesis, directly used in subsequent steps such as heterocyclic modification and salt formation, for the prep…
Molecular Formula (Derived): C₃₄H₃₄F₂N₈O₃ (Based on the previous imidazolinone intermediate, the introduction of an indazole ring adds 9 C, 2 N, and 1 F, resulting in a molecule containing 2 F, 8 N, a…
Molecular Formula (Derived): C₂₅H₃₀FN₅O₃ (Based on the previous intermediate, the amino group is replaced with an imidazolinone ring, adding 4 C, 1 N, and 1 O, containing 1 F, 5 N, and 3 O)Molecular W…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea